Regen BioPharma, Inc. (RGBP)

OTCMKTS · Delayed Price · Currency is USD

0.0010

-0.0001 (-9.09%)

Mar 5, 2026, 9:52 AM EST

Revenue by Segment

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	Sep '19 Sep 30, 2019	Sep '18 Sep 30, 2018	Sep '17 Sep 30, 2017	Sep '16 Sep 30, 2016
Development of Regenerative Medical Applications	236.56K	236.56K	236.56K	235.52K	171.19K
Development of Regenerative Medical Applications Growth	0.00%	0%	0.44%	37.57%	55.63%
Total	236.56K	236.56K	236.56K	235.52K	171.19K
Total Growth	0.00%	0%	0.44%	37.57%	55.63%

Revenue by Geography

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	Sep '19 Sep 30, 2019	Sep '18 Sep 30, 2018	Sep '17 Sep 30, 2017	Sep '16 Sep 30, 2016
United States	236.56K	236.56K	236.56K	235.52K	171.19K
United States Growth	0.00%	0%	0.44%	37.57%	55.63%
Total	236.56K	236.56K	236.56K	235.52K	171.19K
Total Growth	0.00%	0%	0.44%	37.57%	55.63%

Source: S&P Global Market Intelligence.